MedPath

se of Fentanyl injection for cancer pain in childre

Not Applicable
Conditions
Health Condition 1: C969- Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified
Registration Number
CTRI/2023/12/060396
Lead Sponsor
Manipal Academy of Higher Education
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Children with cancer ( >3 to <18 years); Haematolymphoid malignancies; Acute pain (sudden onset pain felt immediately following injury, is severe in intensity but is usually short-lasting. It arises as a result of tissue injury stimulating nociceptors and generally disappears when the injury heals)

Exclusion Criteria

Children with Cognitive impairment and speech impairment; Solid tumours; Patients who are not willing to participate in the study.; Chronic pain (pain with >3 months persistence or recurrence)

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Modelling and qualification of a dose-response based pharmacodynamic model that could be a potential/ tool for clinical use in the future.Timepoint: At random time points within 1-4 hours after drug administration.
Secondary Outcome Measures
NameTimeMethod
a.The prescription pattern of Fentanyl in the patients. <br/ ><br>b.The variables with the highest frequency for Fentanyl usage. <br/ ><br>c.The cost of illness and its predictors. <br/ ><br>Timepoint: At a Single time point before discharge.
© Copyright 2025. All Rights Reserved by MedPath